- NEWS AND VIEWS
A subset of immune-system T cells branded as seeds for type 1 diabetes
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 602, 35-36 (2022)
doi: https://doi.org/10.1038/d41586-021-03800-z
References
Gearty, S. V. et al. Nature 602, 156–161 (2022).
Khan, O. et al. Nature 571, 211–218 (2019).
McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. Annu. Rev. Immunol. 37, 457–495 (2019).
Yao, C. et al. Nature Immunol. 20, 890–901 (2019).
Bluestone, J. A., Herold, K. & Eisenbarth, G. Nature 464, 1293–1300 (2010).
Lin, W.-H. W. et al. Cell Rep. 17, 1773–1782 (2016).
Zhou, X. et al. Immunity 33, 229–240 (2010).
Chen, Z. et al. Immunity 51, 840–855 (2019).
Connolly, K. A. et al. Sci. Immunol. 6, eabg7836 (2021).
Utzschneider, D. T. et al. Immunity 45, 415–427 (2016).
Utzschneider, D. T. et al. Nature Immunol. 21, 1256–1266 (2020).
Competing Interests
The authors declare no competing interests.